| Primary |
| Drug Use For Unknown Indication |
20.2% |
| Product Used For Unknown Indication |
14.1% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
7.6% |
| Bronchitis |
5.3% |
| Pyrexia |
5.3% |
| Asthma |
4.6% |
| Pain |
4.6% |
| Osteoarthritis |
4.2% |
| Neuropathy Peripheral |
3.8% |
| Sinusitis |
3.8% |
| Microscopic Polyangiitis |
3.4% |
| Rash |
3.0% |
| Tocolysis |
3.0% |
| Breast Cancer |
2.7% |
| Dermatitis Atopic |
2.7% |
| Prophylaxis |
2.7% |
| Anaplastic Astrocytoma |
2.3% |
| Diabetes Mellitus |
2.3% |
| Dyspnoea |
2.3% |
| Rhinorrhoea |
2.3% |
|
| Exposure During Pregnancy |
18.6% |
| Pain |
9.3% |
| Vomiting |
9.3% |
| Pain In Extremity |
5.8% |
| Premature Baby |
5.8% |
| Rash Maculo-papular |
5.8% |
| Stevens-johnson Syndrome |
5.8% |
| Pyrexia |
4.7% |
| Maternal Exposure During Pregnancy |
3.5% |
| Pharmaceutical Product Complaint |
3.5% |
| Pneumonia Aspiration |
3.5% |
| Respiratory Arrest |
3.5% |
| Vascular Purpura |
3.5% |
| Weight Increased |
3.5% |
| Angioedema |
2.3% |
| Coma |
2.3% |
| Condition Aggravated |
2.3% |
| Drug Effect Decreased |
2.3% |
| Drug Eruption |
2.3% |
| Drug Exposure During Pregnancy |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
28.2% |
| Drug Use For Unknown Indication |
13.8% |
| Cataract Operation |
8.5% |
| Prophylaxis |
5.0% |
| Foetal Exposure During Pregnancy |
4.1% |
| Asthma |
3.9% |
| Maternal Exposure Timing Unspecified |
3.7% |
| Hiv Infection |
3.6% |
| Pain |
3.3% |
| Preoperative Care |
3.0% |
| Eye Irrigation |
2.5% |
| Bipolar Disorder |
2.4% |
| Otitis Media Acute |
2.4% |
| Neuropathy Peripheral |
2.3% |
| Postoperative Care |
2.3% |
| Pustular Psoriasis |
2.3% |
| Diabetes Mellitus |
2.2% |
| Insomnia |
2.2% |
| Interstitial Lung Disease |
2.2% |
| Testicular Germ Cell Tumour Mixed Stage Iii |
2.2% |
|
| Premature Baby |
17.7% |
| Toxic Anterior Segment Syndrome |
12.7% |
| Foetal Exposure During Pregnancy |
6.3% |
| Osteonecrosis |
5.1% |
| Premature Delivery |
5.1% |
| Solitary Kidney |
5.1% |
| Respiratory Arrest |
4.4% |
| Stevens-johnson Syndrome |
4.4% |
| Vomiting |
4.4% |
| Caesarean Section |
3.8% |
| Pyrexia |
3.8% |
| Exposure During Pregnancy |
3.2% |
| Pneumonia |
3.2% |
| Premature Labour |
3.2% |
| Rash |
3.2% |
| Septic Shock |
3.2% |
| Tendon Rupture |
3.2% |
| White Blood Cell Count Decreased |
3.2% |
| Cerebral Haemorrhage |
2.5% |
| Death |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.5% |
| Prophylaxis |
13.3% |
| Drug Use For Unknown Indication |
13.3% |
| Rheumatoid Arthritis |
7.7% |
| Multiple Myeloma |
5.5% |
| Asthma |
4.6% |
| Hypertension |
4.2% |
| Psoriasis |
3.5% |
| Breast Cancer |
3.0% |
| Constipation |
3.0% |
| Pain |
2.7% |
| Cancer Pain |
2.5% |
| Ovarian Cancer Recurrent |
2.3% |
| Insomnia |
2.2% |
| Depression |
2.0% |
| Behcet's Syndrome |
2.0% |
| Hepatitis C |
1.8% |
| Crohn's Disease |
1.7% |
| Renal Cell Carcinoma |
1.6% |
| Diabetes Mellitus |
1.5% |
|
| Premature Baby |
12.8% |
| Pyrexia |
6.8% |
| Premature Labour |
6.7% |
| Vomiting |
6.7% |
| Interstitial Lung Disease |
6.5% |
| Platelet Count Decreased |
5.7% |
| Rash |
5.7% |
| Thrombocytopenia |
5.0% |
| Weight Increased |
5.0% |
| Pneumonia |
4.8% |
| White Blood Cell Count Decreased |
4.8% |
| Weight Decreased |
4.6% |
| Small For Dates Baby |
4.1% |
| Pain |
3.8% |
| Toxic Epidermal Necrolysis |
3.4% |
| Renal Failure |
3.1% |
| Drug Exposure During Pregnancy |
2.7% |
| Stevens-johnson Syndrome |
2.7% |
| Respiratory Failure |
2.6% |
| Somnolence |
2.6% |
|
| Interacting |
| Hiv Infection |
19.4% |
| Cystoid Macular Oedema |
9.7% |
| Cytomegalovirus Chorioretinitis |
9.7% |
| Product Used For Unknown Indication |
9.7% |
| Uveitis |
9.7% |
| Vertigo |
9.7% |
| Antiretroviral Therapy |
4.8% |
| Pruritus |
4.8% |
| Skin Ulcer |
4.8% |
| Asymptomatic Hiv Infection |
3.2% |
| Back Pain |
3.2% |
| Macular Oedema |
3.2% |
| Arrhythmia |
1.6% |
| Ear Infection |
1.6% |
| Epilepsy |
1.6% |
| Mitral Valve Replacement |
1.6% |
| Sleep Disorder |
1.6% |
|
| Weight Increased |
33.3% |
| Adrenal Suppression |
11.1% |
| Blood Cholesterol Increased |
11.1% |
| Constipation |
11.1% |
| Cushing's Syndrome |
11.1% |
| Infection |
11.1% |
| Prothrombin Time Shortened |
11.1% |
|
